Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000612046 | SCV000728976 | likely benign | not specified | 2017-06-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV004563346 | SCV000768387 | likely benign | Familial adenomatous polyposis 1 | 2024-05-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002385945 | SCV002671243 | likely benign | Hereditary cancer-predisposing syndrome | 2019-09-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV002385945 | SCV004356801 | likely benign | Hereditary cancer-predisposing syndrome | 2022-11-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004563346 | SCV005082745 | benign | Familial adenomatous polyposis 1 | 2024-04-09 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV003980180 | SCV004787524 | likely benign | APC-related disorder | 2019-04-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |